Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM6NG3C)

Drug Name

CMV glycoprotein B subunit vaccine Drug Info

Synonyms

CMV gB subunit vaccine, GlaxoSmithKline; CMV glycoprotein B subunit vaccine, GlaxoSmithKline; Cytomegalovirus glycoprotein B subunit vaccine, GlaxoSmithKline; GSK-1492903-A

Indication

Disease Entry	ICD 11	Status	REF
Cytomegalovirus infection	1D82	Phase 1	[1]

Cross-matching ID

TTD Drug ID: DM6NG3C

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Cytomegalovirus Glycoprotein B (CMV gB)	TTUR18Y	GB_HCMVA	Not Available	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT00435396) Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of GlaxoSmithKline.